Netflix adds 5.3M subscribers in Q3 >>> READ MORE

3 Huge Healthcare Trends Can Fatten Your Portfolio

Invest in healthcare trends

      View All  

Treating Diabetes

The major manufacturers of insulin, the main treatment for diabetes, are Novo Nordisk (NVO),Sanofi-Aventis (SNY) and Eli Lilly (LLY). Global sales related to diabetes are a staggering $15.4 billion annually, increasing 400% since 2000.

It is predicted that by 2050, 20% to 30% of the U.S. population will have diabetes, mostly with obese-driven Type 2. United Healthcare estimates that Americans will spend $3.4 trillion over the next 10 years in diabetes-related costs.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC